Loring Wolcott & Coolidge Fiduciary Advisors’s LumiraDx Limited Common Shares LMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,820
Closed -$196 595
2023
Q4
$196 Hold
12,820
﹤0.01% 549
2023
Q3
$1.23K Hold
12,820
﹤0.01% 589
2023
Q2
$6.15K Hold
12,820
﹤0.01% 567
2023
Q1
$5.96K Hold
12,820
﹤0.01% 540
2022
Q4
$11.5K Hold
12,820
﹤0.01% 496
2022
Q3
$13K Buy
+12,820
New +$21.3K ﹤0.01% 517

Other funds holding LMDX

Loring Wolcott & Coolidge Fiduciary Advisors's LMDX Position: Q1 2024 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of LumiraDx Limited Common Shares (LMDX) in Q1 2024, closing a stake of 12,820 shares — an estimated $196 sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LMDX in Q3 2022 and held it in 6 quarters. The position peaked at $13K in Q3 2022. 4 funds tracked by Wall St. Rank hold LMDX as of Q1 2024.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining LumiraDx Limited Common Shares position as of Q1 2024 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 12,820 LumiraDx Limited Common Shares shares in Q1 2024, an estimated $196.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in LumiraDx Limited Common Shares in Q3 2022 and held it in 6 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's LumiraDx Limited Common Shares position peaked at $13K in Q3 2022.
  • 4 funds tracked by Wall St. Rank held LumiraDx Limited Common Shares as of Q1 2024.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.